the MHRA felt that the warnings were insufficient

A word of warning from the Medicines and Health Care Products Regulatory Agency is that the smoking cessation medication Champix should not be used by people who are driving. The labelling on the medication at present does warn people that the medication can cause you to the feel dizzy or sleepy however the MHRA felt that the warnings were insufficient and needed to be made stronger.

The actual reason for this change in labelling is because two users of the Champix medication had car accidents the earlier this year. It has not been actually confirmed that the drivers actually had the accident as a result of using the Champix drug but nevertheless the Medicines & Health Care Products Regulatory Agency felt that they should stay on the side of caution especially after the crashes were reported to them.

In all it is estimated at around 2 million men and women have taken the Champix smoking cessation drug in America and in the clinical trials which were conducted in the United Kingdom 4,000 people took part. Champix is reckoned to be the most successful smoking cessation drug around the world at present and it is made by the pharmaceutical giant Pfizer. Unlike most smoking cessation medications Champix works on the receptors in the brain that manage the desire to light up and smoke.

The new labeling for the Champix drug will state that people using it should not drive, operate machinery of any sort or put themselves in any potentially hazardous situations until they are sure that the medication does not affect their coordination significantly. The smoking cessation drug Champix is a prescription medication and must be taken for between 3 and 6 months depending on your level of addiction to nicotine.